Skip Navigation Linksprescription-drug-costs-usage-and-outcomes-19H9

Prescription Drug Costs, Usage and Outcomes: Practical Insights From Research

Sunday, May 5, 2019
Fairmont Copley Plaza Hotel, Boston, MA
Conference begins in:

A Harvard Medical School Executive Education Program for the International Foundation of Employee Benefit Plans

Separate Fact From Fiction Regarding Prescription Drugs

Prescription drugs are a major contributor to the expense of your health plan. It is imperative you understand the broad forces at work and ways to mitigate costs to your plan in order to succeed.

Prescription Drug Costs, Usage and Outcomes: Practical Insights from Research is a one-day program presented by Harvard Medical School faculty and other industry innovators that will use research-based data to separate the truth from fiction on prescription drug topics.

Attend this unique opportunity to reveal strategies to effectively work with pharmacy benefit managers (PBMs) and benefits consultants, ways to utilize your plan design to promote drug adherence and discuss what factors your plan can or cannot have on influencing the market.

This program is being held prior to the Health Care Management Conference, May 6-8, 2019. Extend your time and delve deeper into how possible changes in the health care system can impact your funds.

2019 Topics

Topics for this one-day program are:

  • Assessing Drug Value
  • Utilization/Demand Management in Specialty Drug Plan Design
  • Value-Based Plan Design: Evaluating Models for Drug Purchasing and Reimbursement Including Outcomes-Based Contracting
  • Academic Detailing: Why meeting the information needs of health care professionals is important for appropriate prescribing

 Content Editor ‭[6]‬

​​Who Should Attend?

​This program is structured to fit the educational needs of senior-level group health benefit decision makers. 

​Facul​ty Advisor​​​

​​​Jeff Levin-Scherz Photo.jpg

Jerome L. (Jerry) Avorn, M.D.Professor of Medicine
Harvard Medical School

Chief Emeritus of the Division of
Pharmacoepidemiology and Pharmacoeconomics
Department of Medicine
Brigham and Women’s Hospital

Jeff Levin-Scherz Photo.jpg

Aaron Kesselheim, M.D., J.D.,M.P.H.Associate Professor of MedicineHarvard Medical School
Faculty Member, Division of Pharmacoepidemiology andPharmacoeconomicsDepartment of MedicineBrigham and Women’s Hospital

 Faculty and Speakers

Distinguished faculty and expert speakers for this program have not been announced yet. Please check back soon.

​Progra​m Structure​

Limited seats are being offered at this program to foster discussion and allow for optimal access to Harvard Medical School faculty and researchers. Sessions will utilize small group discussion, case study review and faculty-led lecture.

More Information

For more information regarding this program, please contact Tiffany Ulbing, CEBS at (262) 373-7652 or

Connect with usfacebook-icon-white-red.pngfacebook-icon-white-red.pngfacebook-icon-white-red.png #IFEBP

Registration Information

Registration Information
  Member Nonmember

Through 3/25/2019 US $995.00 US $1,195.00
After 3/25/2019 US $1,295.00 US $1,495.00